Avantia Labs delivers high-precision biomarker analysis supporting biologics, vaccines, and gene therapy programs from discovery to clinical development.
Our scientists combine ligand-binding, immunoassay, and molecular platforms to reveal pharmacodynamic effects, safety profiles, and immunogenicity risks — empowering data-driven therapeutic insights.
Precision biomarker analysis for biologics & gene therapy
Biomarker Services
Avantia Labs delivers quantitative & qualitative biomarker profiling using ligand-binding, immunoassay, and molecular platforms—with GLP/GCLP rigor and 21 CFR Part 11 compliance.
Biomarkers that translate data into decisions.
What we help you achieve
Comprehensive biomarker strategy | GLP/GCLP-compliant bioanalysis | Regulatory-ready data | Precision insights for translational research
Target Partners
- Biotech & Pharma Companies
- Academic Translational Centers
- Clinical Research Organizations
- Gene & Cell Therapy Developers
- Diagnostic Innovators
Our Specialties
- Quantitative Immunoassays (ELISA / MSD / Luminex)
- Molecular Biomarker Testing (ddPCR / qPCR)
- Flow Cytometry & Cell-Based Assays
- Multiplex Cytokine Panels
- Method Validation & Data Interpretation
Featured Studies
- Immunogenicity & Translational Biomarkers
- PK/PD Correlation Studies
- Early Safety Signal Detection
- Clinical Efficacy Assessment
Recognized Strengths
- GLP/GCLP-Compliant Operations
- Rapid Method Development & Transfer
- Deep Expertise in Biologics & CGT Programs
- 21 CFR Part 11-Compliant Data Systems
- Strong QA & Regulatory Alignment
Biomarker Analysis Process: From Discovery to Clinical Validation
Item No.
01. Discovery & Feasibility
Avantia Labs begins with a focused biomarker feasibility assessment to identify optimal analytes, assay platforms, and matrices.
We evaluate sensitivity, stability, and biological relevance to ensure your biomarker program starts with a solid scientific foundation.
Item No.
02. Method Development & Validation
Our scientists develop fit-for-purpose assays using ELISA, MSD, and ddPCR, validated under GLP/GCLP and FDA/EMA guidelines to ensure precision, accuracy, and reproducibility.
Item No.
03. Clinical Analysis & Interpretation
Our team performs high-throughput clinical biomarker analysis with full data integrity.
We integrate PK/PD correlation and mechanistic interpretation to deliver actionable results that drive clinical and regulatory decisions.
Quality. Sensitivity. Translational Value
Comprehensive Biomarker Solutions for Biologics and Gene Therapy
Accelerate Your Biomarker Program with Scientific Precision
Partner with Avantia Labs to turn complex biomarker data into actionable clinical insights.
